For the past 40 years, Gregory Pavlov has been engaged in clinical trials data management and related research efforts in a range of technical and managerial capacities, including database administrator, programmer analyst, director of data management and computing for ACTG and IMPAACT clinical trials, and director of the Frontier Science Amherst, New York office.

Mr. Pavlov was President of Frontier Science from July 2014 until July 2017. Throughout his career, Mr. Pavlov created systems that facilitated national and international trials collaboration including clinical trials networks such as the CALGB, ECOG, IBCSG and RTOG; trials conducted by the Dana-Farber and other research institutes; and various industry sponsors.